The findings suggest the dominant “two-hit” hypothesis of cancer development may not tell the full story behind how cancer ...

HMS alumni Keith Dunleavy, founder and CEO of health care technology company Inovalon, and his wife, Katherine Dunleavy, a ...

The results, published Nov. 7 in Current Biology, reveal that some of the stories told for decades about the individuals’ ...

The heart tissue showed upregulation of molecular pathways that help recruit and retain immune cells involved in inflammation. Patients with active disease also had greater abundance of clusters of ...

Breast cancer rates rose by 1 percent per year from 2012-2021 for all U.S. women combined, with steeper increases for women under 50 and Asian American and Pacific Islander women, according to the ...

David Walt, the Hansjörg Wyss Professor of Bioinspired Engineering at HMS and professor of pathology at Brigham and Women’s Hospital, is operating at a microscopic level, observing cell abnormalities ...

CHASERR is unlike traditional genes, which are used as blueprints for making messenger RNA and proteins that perform various functions in cells. Instead, CHASERR codes for a long noncoding RNA, or ...

We know that many things influence people’s health, including genetics, behavior, environmental exposure, and socioeconomic factors. One contributor, however, often goes unappreciated: civic ...

Gary Ruvkun, professor of genetics at Harvard Medical School and an investigator at Massachusetts General Hospital, received the 2024 Nobel Prize in Physiology or Medicine for his co-discovery of ...

Vivian Kobusingye Birchall, SM, is the host of ActonTV’s Health Care Blind Spots Series, where she interviews stakeholders, physicians, researchers, and industry policymakers on the status of cancer ...